Studies in Translational Regenerative Medicine
Studies in Translational Regenerative Medicine
批准号:
9133376
负责人:
ANTHONY ATALA
金额:
$18.41万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-01 至 2018-08-31
中文摘要
描述(由申请人提供):再生医学包括组织工程和自我修复,该学科已成为一个非常有价值的学科,对改善人类健康具有巨大的影响。虽然再生医学(WFIRM)的维克森林研究所在其短暂的存在有响亮的成功,我们缺乏一个综合的机制,以支持代表再生医学研究人员的下一代的博士前学生的培训。因此,我们寻求支持一个新的T32培训计划,以满足这一需求。 拟议的计划是WFIRM研究人员正在进行的多学科合作的逻辑延伸,所有这些都位于维克森林医学院市中心校园的一座新的国家建筑内。WFIRM拥有独特的基础设施,为转化研究提供设施和专业知识,从基本的临床前发现一直到2期临床试验。培训将包括传统的教学课程工作,各种WFIRM范围内的培训活动,参与尖端研究项目,赠款写作和科学演示,以及接触再生医学中的伦理问题。将有6个研究重点领域:1)泌尿科~ 2)心血管~ 3)肌肉骨骼~ 4)内分泌组织~ 5)干细胞~ 6)生物材料/使能技术。 每个重点领域包含至少五名具有互补专业知识的教师,他们将作为共同导师参与研究生的培训和监督。学生将从WFU研究生院新配置的结构中的3个轨道中选择:分子和细胞生物科学,生物医学工程或综合生理学和药理学。在一个共同的第一年课程(这是独特的每个轨道)后,学生将确定我们的10个主要导师之一(19个总计划教师),采取两个额外的再生医学为基础的课程,并选择一个研究生委员会,将指导学生通过他们的论文工作。项目总监乔治基督博士对培训项目的管理负有最终责任,由安东尼·阿塔拉博士(副总监)和由经验丰富的高级培训师组成的执行委员会协助。 拟议的指导结构的一个新方面是包括经验丰富的教师(初级导师~ 10),年轻的教师(培训导师~ 5),和资深教师,有职业生涯的长期指导经验(名誉导师~ 4)。培训计划将由内部咨询委员会和外部咨询委员会每年进行审查和评估,其成员具有管理培训计划以及全国知名的再生医学研究计划的丰富经验。 鉴于WFIRM的世界级地位,我们广泛的国内和国际合作,以及我们的研究生课程的重组,以反映多学科培训的需要,这个应用程序提供了一个独特的培训机会。因此,这一建议是及时的,深思熟虑的
计划,并专门设计,以满足在再生医学的许多方面训练有素的调查人员迅速增长的需求。
英文摘要
DESCRIPTION (provided by applicant): Regenerative medicine encompasses both tissue engineering and self-healing, and the discipline has emerged as a hugely valuable one with immense ramifications for improving human health. While the Wake Forest Institute of Regenerative Medicine (WFIRM) has had resounding success in its short existence, we lack an integrated mechanism to support training of the pre-doctoral students that represent the next generation of regenerative medicine researchers. Thus, we seek support for a new T32-training program to meet this need. The proposed program is a logical extension of the ongoing multidisciplinary collaboration of investigators at WFIRM, all located in a new state-of-the-at building on the downtown campus of Wake Forest School of Medicine. WFIRM has a unique infrastructure that provides facilities and expertise for translational studies, from basic preclincal findings all the way through Phase 2 clinical trials. Training will include traditional didactic course work, a variety of WFIRM-wide training activities, participation in cutting-edge research projects, grant writing, and scientific presentations, and exposure to ethical issues in regenerative medicine. There will be 6 areas of research focus: 1) urological~ 2) cardiovascular~ 3) musculoskeletal~ 4) endocrine tissue~ 5) stem cells~ & 6) biomaterials/enabling technologies. Each area of focus contains at least five faculty members with complementary expertise, who will participate in the training and supervision of graduate students as co- mentors. Students will be selected from 3 Tracks within the newly configured structure of the WFU Graduate School: Molecular and Cellular Biosciences, Biomedical Engineering, or Integrative Physiology and Pharmacology. After a common 1st year curriculum (that is unique to each track), students will identify one of our 10 primary mentors (of the 19 total program faculty), take two additional regenerative medicine-based courses, and choose a graduate committee that will guide the student through their thesis work. The Program Director, Dr. George Christ, has ultimate responsibility for the administration of the Training program, assisted by Dr. Anthony Attala (the Associate Director) and an Executive Committee composed of senior experienced trainers. A novel aspect of the proposed mentoring structure is the inclusion of seasoned faculty (Primary Mentors~ 10), young rising faculty (Mentors in Training~ 5), and senior faculty that have career-long mentoring experience (Emeritus Mentors~ 4). The training program will be reviewed and evaluated annually by an Internal Advisory Committee and by an External Advisory Committee, whose members have extensive experience managing training programs as well as nationally renowned research programs in regenerative medicine. Given the world-class stature of WFIRM, our extensive national and international collaborations, and the restructuring of our graduate program to reflect the need for multi-disciplinary training, this application provides a unique training opportunity. As such, this proposal is timely, thoughtfully
planned, and specifically designed to meet the burgeoning need for well-trained investigators in the many facets of regenerative medicine.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
U2C/TL1 NC KUH TRIO Program
-
批准号:10725470
-
项目类别:
-
资助金额:$48.82万
-
财政年份:2023
-
负责人:ANTHONY ATALA
-
依托单位:
Bioengineered Tissues For Uterine Reconstruction
-
批准号:10420259
-
项目类别:
-
资助金额:$58.98万
-
财政年份:2022
-
负责人:ANTHONY ATALA
-
依托单位:
Bioengineered Tissues For Uterine Reconstruction
-
批准号:10582724
-
项目类别:
-
资助金额:$49.69万
-
财政年份:2022
-
负责人:ANTHONY ATALA
-
依托单位:
Bioprinting Patterning for Cell-Laden Constructs
-
批准号:9279982
-
项目类别:
-
资助金额:$27.13万
-
财政年份:2017
-
负责人:ANTHONY ATALA
-
依托单位:
Studies in Translational Regenerative Medicine
-
批准号:10663320
-
项目类别:
-
资助金额:$16.55万
-
财政年份:2013
-
负责人:ANTHONY ATALA
-
依托单位:
Studies in Translational Regenerative Medicine
-
批准号:9344634
-
项目类别:
-
资助金额:$16.03万
-
财政年份:2013
-
负责人:ANTHONY ATALA
-
依托单位:
Studies in Translational Regenerative Medicine
-
批准号:8721955
-
项目类别:
-
资助金额:$9.18万
-
财政年份:2013
-
负责人:ANTHONY ATALA
-
依托单位:
Studies in Translational Regenerative Medicine
-
批准号:10178010
-
项目类别:
-
资助金额:$19.97万
-
财政年份:2013
-
负责人:ANTHONY ATALA
-
依托单位:
Insulin Producing Cells from Amniotic Stem Cells for Diabetes Therapy
-
批准号:7630939
-
项目类别:
-
资助金额:$11.1万
-
财政年份:2008
-
负责人:ANTHONY ATALA
-
依托单位:
The Harvard Urologic Research Center
-
批准号:7500536
-
项目类别:
-
资助金额:$15.75万
-
财政年份:2007
-
负责人:ANTHONY ATALA
-
依托单位:
Insulin Producing Cells from Amniotic Stem Cells for Diabetes Therapy
-
批准号:7500809
-
项目类别:
-
资助金额:$102.51万
-
财政年份:2007
-
负责人:ANTHONY ATALA
-
依托单位:
Insulin Producing Cells from Amniotic Stem Cells for Diabetes Therapy
-
批准号:7676078
-
项目类别:
-
资助金额:$102.51万
-
财政年份:2007
-
负责人:ANTHONY ATALA
-
依托单位:
Insulin Producing Cells from Amniotic Stem Cells for Diabetes Therapy
-
批准号:7880311
-
项目类别:
-
资助金额:$3.88万
-
财政年份:2007
-
负责人:ANTHONY ATALA
-
依托单位:
Insulin Producing Cells from Amniotic Stem Cells for Diabetes Therapy
-
批准号:7343611
-
项目类别:
-
资助金额:$105.8万
-
财政年份:2007
-
负责人:ANTHONY ATALA
-
依托单位:
PROJECT 1
-
批准号:7661996
-
项目类别:
-
资助金额:$18.85万
-
财政年份:2006
-
负责人:ANTHONY ATALA
-
依托单位:
PROJECT 1
-
批准号:7661964
-
项目类别:
-
资助金额:$19.43万
-
财政年份:2005
-
负责人:ANTHONY ATALA
-
依托单位:
MOLECULAR GENETIC ANALYSIS OF VESICOURETERAL REFLUX IN PATIENTS & THEIR FAMILIES
-
批准号:6568548
-
项目类别:
-
资助金额:$2.88万
-
财政年份:2001
-
负责人:ANTHONY ATALA
-
依托单位:
MOLECULAR GENETIC ANALYSIS OF VESICOURETERAL REFLUX IN PATIENTS & THEIR FAMILIES
-
批准号:6485554
-
项目类别:
-
资助金额:$2.88万
-
财政年份:2000
-
负责人:ANTHONY ATALA
-
依托单位:
MOLECULAR GENETIC ANALYSIS OF VESICOURETERAL REFLUX IN PATIENTS & THEIR FAMILIES
-
批准号:6441955
-
项目类别:
-
资助金额:$2.88万
-
财政年份:2000
-
负责人:ANTHONY ATALA
-
依托单位:
BIOENGINEERING OF BLADDER TISSUES
-
批准号:6643565
-
项目类别:
-
资助金额:$7.44万
-
财政年份:1999
-
负责人:ANTHONY ATALA
-
依托单位:
海外基金